Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled C... by Gil Yosipovitch, Jennifer Soung, Jonathan Weiss, Elisa Muscianisi, Xiangyi Meng, Isabelle Gilloteau, Boni E. Elewski

Get full text

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials by Alice B. Gottlieb, Jashin J. Wu, Christopher E. M. Griffiths, Kwaku Marfo, Elisa Muscianisi, Xiangyi Meng, Jennifer Frueh, Mark Lebwohl

Get full text

Patient perspectives on diagnosis and management of hidradenitis suppurativa: A web-based survey by Jennifer L. Hsiao, MD, Vivian Y. Shi, MD, Elisa Muscianisi, MD, Elizabeth Nguyen, PharmD, John Darcy, II, PhD, Joslyn S. Kirby, MD

Get full text

A survey of dermatologist perspectives on disease management of patients with hidradenitis suppurativa by Vivian Y. Shi, MD, Jennifer L. Hsiao, MD, Elisa Muscianisi, MD, Elizabeth Nguyen, PharmD, John Darcy, II, PhD, Joslyn S. Kirby, MD

Get full text

Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results) by Jerry Bagel, John Nia, Peter W. Hashim, Manmath Patekar, Ana de Vera, Sophie Hugot, Kuan Sheng, Summer Xia, Isabelle Gilloteau, Elisa Muscianisi, Andrew Blauvelt, Mark Lebwohl

Get full text